[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk (NYSE: NVO) has made headlines lately with updates to its Wegovy lineup, including a new oral pill...
Wegovy
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk (NYSE: NVO) deals in diabetes and obesity medications. Wegovy stands out as one of its key products....
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NYSE: NVO) has announced plans to cut the official list prices of some of its most...
[stock_market_widget type=”card” template=”basic2″ assets=”HIMS” realtime=”true” api=”yahoo-finance”] Hims & Hers Health, Inc. (NYSE: HIMS) just shook up the weight loss drug market with plans to sell...
[stock_market_widget type=”card” template=”basic” color=”#5679FF” assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NYSE: NVO, CPH: NOVO-B) opened trading over 9% higher after U.S. regulators cleared an oral...
